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http://www.hqlo.com/content/12/1/161RESEARCH Open AccessHow is the most severe health state being valued
by the general population?
Mihir Gandhi1,2,3*, Julian Thumboo4,5, Hwee-Lin Wee6, Nan Luo7 and Yin-Bun Cheung1,2,3Abstract
Background: It has been reported that valuation of health states that are close to death, such as the most severe
health state, can be affected by health state valuation procedure, and their utility values are difficult to predict. We
examined how the most severe health states of Short Form-6 dimension (SF-6D) and EuroQoL-5 dimension-3 level
(EQ-5D-3L) were valued by the Singapore general population.
Methods: Overall, 249 SF-6D and 42 EQ-5D-3L states were valued by two separate samples from the Singapore
general population using the visual analogue scale (VAS) method. Ordinary least-square regression model was
employed to explain deficit in the valuation of the most severe state using the health state descriptors.
Results: A total of 1021 participants from the SF-6D sample and 1015 participants from the EQ-5D-3L sample were
included in the analysis. We observed that 67% of the SF-6D participants and 74% of the EQ-5D-3L participants
considered the most severe state worse than dead. The most severe state had mean VAS valuation scores more
than 20–25 points lower than the adjacent states that are better by only one level in only one dimension. SF-6D
VAS valuation score for the most severe state was 27 points and 12 points lower than expected according to the
health state descriptors among the participants who considered the most severe state worse than dead and better
than dead, respectively. Similar results were found for the EQ-5D-3L valuation.
Conclusions: The most severe health state was valued lower than expected according to its descriptors.
Keywords: EQ-5D, SF-6D, Utility, Visual analogue scale, Worse than deadBackground
There is an increasing demand on evaluating the outcome
of health-care interventions using cost utility analysis
(CUA), and various health regulatory bodies consider it the
main approach for evaluating the outcome of health-care
interventions [1]. CUA involves quality adjusted life years
(QALYs), which are estimated as the time spent in a health
state multiplied by its utility. QALYs are very useful as they
capture changes in both quality and quantity of life. Health
states from generic health outcome instruments such as
EuroQoL-5 dimension (EQ-5D), Short Form-6 dimension
(SF-6D) and Health Utility Index Mark 3 (HUI3) are val-
ued by the general population using one or more valuation
methods such as time trade-off (TTO), standard gamble
(SG) and visual analogue scale (VAS) [2]. A number of* Correspondence: mihir.gandhi@scri.edu.sg
1Centre for Quantitative Medicine, Office of Clinical Sciences, Duke-NUS
Graduate Medical School, Singapore, Singapore
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Dedication waiver (http://creativecommons.or
unless otherwise stated.health states with a mixture of severity levels, including
perfect health, dead and the most severe health state de-
scribed by the instrument, are valued by each participant.
The utility of perfect health is valued 1 and dead is valued
0. A negative utility value represents that the health state is
considered ‘worse than dead’.
The most severe health state is an important health
state in valuation studies. Usually either the most severe
health state or dead state is the least valued state and
hence decides the lower bound of utility values [3]. For
example, the valuation studies in several European coun-
tries asked participants to value the most severe health
state along with the perfect health and dead state twice
because these states are anchoring states (lower or upper
bound of the utility values) [4]. Some valuation methods,
such as chained TTO and chained SG, also use the most
severe health state as the ‘temporary health state’ and
ask participants to trade-off or gamble the other healthLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Gandhi et al. Health and Quality of Life Outcomes 2014, 12:161 Page 2 of 7
http://www.hqlo.com/content/12/1/161states between the perfect health and the most severe
health state [5].
The most severe health state is often labelled as ‘all-
worst’ or ‘pits’ [6-10]. There is a general consensus that
adding a disease label in disease-specific health state de-
scriptions can have an impact on health state value, pos-
sibly due to prior knowledge or preconception of the
disease [11]. However, no study to our knowledge has
investigated the impact of labeling a generic health state.
Valuation of health states based on generic instruments
is the most common method for eliciting the population
preferences in CUA, thus how the most severe health state
(in the presence of a label) is valued needs attention.
Drawing on data from a valuation study of the two
most commonly used generic instruments, namely SF-
6D and EQ-5D-3 level (EQ-5D-3L), we aim to examine
how the most severe health state is valued by the par-
ticipants. In this study, the most severe health state
was labelled as ‘all-worst’ state. A valuation study in
multi-ethnic Asian general population showed that the
majority of participants felt that ‘all-worst’ is a better
description than ‘pits’ for the most severe health state
of EQ-5D [12].
Methods
Valuation survey procedures
A cross-sectional, face-to-face survey of health state
valuation for SF-6D and EQ-5D-3L using the VAS
method was conducted in 2009 from a representative
sample of the general population of Singapore, a multi-
ethnic Asian country. A multi-stage sampling approach
was used to randomly select residential blocks, within
which households were selected. Potential participants
who satisfied the pre-set recruitment quotas for ethnicity
(400 Chinese, 400 Malay, 234 Indian), gender (50%
Female) and age (30% for 21–34 years, 40% for 35–49
years, 30% for 50+ years) were interviewed. Within each
race, there was a quota that half of the participants
would use English and the remaining half would use
their native language for the interviews, i.e. Mandarin
for Chinese, Malay for Malays and Tamil for Indians.
Two separate samples of 1034 participants each were
selected for the SF-6D and EQ-5D-3L health states valu-
ation. The SF-6D consists of 6 dimensions (physical
functioning, role limitations, social functioning, pain,
mental health and vitality) and each dimension has 4 to
6 levels. Thus, SF-6D describes a total of 18,000 health
states. A subset of 249 SF-6D states was selected (out
of 18,000) for the valuation based on the protocol of
Brazier et al. [6]. The most severe state (‘645655’ for
SF-6D) was labeled as ‘all-worst’. Each participant was
asked to compare between ‘dying now’ and ‘living for
the rest of his/her life in all-worst’, from which the less
desirable state was assigned a value 0 on the VAS. Eachparticipant was then asked to value a unique set of 6
states from the subset of SF-6D states and either dead
or the ‘all-worst’ state, depending on which one was not
valued earlier at 0. The unique set of 6 health states
were assigned to each participant in a way that they
spread widely over the valuation space. A 100-point
“feeling thermometer” with endpoints of 100 (most de-
sirable, i.e. perfect health) and 0 (least desirable) was
used as the VAS. The participants were required to in-
dicate where they would rate each of the assigned states
on the “feeling thermometer” by imagine themselves in
that state for the rest of their life without changing.
The participants were allowed to value more than one
health state at the same level of VAS.
The valuation of EQ-5D-3L states was carried out in a
similar way as SF-6D. The EQ-5D-3L consists of 5 di-
mensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression) with 3 levels each (no
problems, some problems, and extreme problems) and
thus describes 243 health states. A subset of 42 EQ-5D-
3L states was selected based on the protocol of Dolan
[13]. The most severe state (‘33333’) was labeled as ‘all-
worst’. Unconscious state was also valued in addition to
the other 6 assigned states.
The study was approved by SingHealth Centralized
Institutional Review Board.Analyses
Participants who met the following criteria were ex-
cluded from our analysis: a) valued less than 3 health
states, b) did not value dead or the ‘all-worst’ state, c)
valued dead or the ‘all-worst’ state or unconscious state
higher than all the other states, d) gave the same valu-
ation score to all the health states, e) self-reported or
rated by the interviewers as having poor understanding
of health states description or valuation tasks. The valu-
ation score used in the analyses was ‘raw’ VAS valuation
score ranging from 0 (worst possible score) to 100 (best
possible score). We did not transform the valuation
scores to utility to avoid an impact of the transformation
on the estimated valuation score [3].
Mean valuation scores of the health states are pre-
sented using line graphs for a subset of selected health
states. As the study has valued many health states, to
maintain visual clarity we did not include all the valued
health states. The lowest ten health states with the least
valuation scores near the dead state were included in the
graphs. Health states with higher valuation scores were
systematically skipped for the graphical presentation.
The valuation scores among the participants who con-
sidered the ‘all-worst’ state worse than dead and who
considered the ‘all-worst’ state better than dead were
presented separately in the graphs.
Table 1 Demographic and health characteristics of the
study sample participants
Characteristics, n (%)
Participants
completing
the SF-6D
Participants
completing
the EQ-5D-3L
(N = 1021) (N = 1015)
Female 521 (51.0) 512 (50.4)
Age (years)
21-29 190 (18.6) 194 (19.1)
30-39 222 (21.7) 228 (22.5)
40-49 272 (26.6) 269 (26.5)
50-59 206 (20.2) 200 (19.7)
60+ 131 (12.8) 124 (12.2)
Ethnicity
Chinese 392 (38.4) 387 (38.1)
Malay 396 (38.8) 399 (39.3)
Indian 233 (22.8) 229 (22.6)
Education level
Primary (6 years) or less 177 (17.3) 190 (18.7)
Secondary (11 years) 562 (55.0) 576 (56.8)
Diploma/degree or higher 282 (27.6) 249 (24.5)
Married/partner 765 (74.9) 761 (75.0)
Employed or self-employed 659 (64.5) 643 (63.4)
General health status
Poor 4 (0.4) 8 (0.8)
Fair 70 (6.9) 99 (9.8)
Good 443 (43.4) 424 (41.8)
Very good 419 (41.0) 383 (37.7)
Excellent 85 (8.3) 101 (10.0)
Self-reported health on EQ-5D-3L VAS,
Mean (SD)
84.5 (11.2) 83.0 (12.1)
VAS = visual analogue scale.
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model for EQ-5D-3L with valuation score as the
dependent variable and indicator variables representing
level of severity for each dimension as the independent
variables, with an intercept [4]. That is, included 2 indi-
cator variables for each of the 5 dimensions of EQ-5D-
3L. We also included an indicator variable (N3) to take
into account of additional disutilities when severe prob-
lem (level 3) is reported on at least one dimension. In
addition to the above commonly used variables, we in-
cluded two indicator variables D1 and D2 and their inter-
action: D1 represented the participant who considered
the ‘all-worst’ state worse than dead and D2 represented
the ‘all-worst’ state. This model helped to assess whether
there was a deficit in the valuation score for the most se-
vere state even after taking the descriptors (levels and di-
mensions) into account. It also assessed possible impact
of considering the most severe state worse than death
on its valuation.
Similar regression analysis model was used to study
SF-6D valuation scores. For the variable N3, the severe
level was defined as levels 4–6 for physical functioning,
levels 3–4 for role limitation, level 4–5 for social func-
tioning, mental health and vitality, and level 5–6 for
pain [6].
All the health states valued in the study were included
in the regression analysis. Perfect health state was not
included in the models, as it was assigned a value 100
on VAS. The dead and unconscious states were also
excluded from the regression analyses as they do not
represent any health states/dimensions of SF-6D or EQ-
5D-3L. Since each of the participants valued 6 health
states, we used the Eicker-Huber-White robust standard
error for clustered data for statistical inference [14]. A
P-value less than 0.05 was considered statistically signifi-
cant. All the analyses were carried out using Stata/MP
10.1 for Windows.
Results
Demographic and health characteristics information was
received from all 1034 participants of the SF-6D sample.
Seven participants valued dead higher than all the other
states; 1 participant valued the ‘all-worst’ state higher
than all the other states; and 5 participants were observed
to have poor understanding of heath states description
and/or valuation tasks. Hence, these 13 participants were
excluded from the SF-6D related analysis. Table 1 shows
demographic and health characteristics of 1021 partici-
pants for the SF-6D valuation that were included in the
analysis. Due to the pre-specified quota for gender, age
and ethnicity, the demographic characteristics of enrolled
participants were similar to what was planned. The major-
ity of the SF-6D participants were married (n = 765, 75%),
employed/self-employed (n = 659, 65%), had at leastsecondary education (n = 844, 83%), and self-reported
good to excellent general health (n = 947, 93%).
Similarly in the EQ-5D-3L sample, 12 participants val-
ued dead higher than all the other states; 2 participants
valued the unconscious state higher than all the other
states; 1 participant did not value the ‘all-worst’ state;
and 4 participants were observed to have poor under-
standing of heath states description and/or valuation
tasks. Hence, 19 participants were excluded from the
EQ-5D-3L related analysis. The demographic and health
characteristics of the EQ-5D-3L participants were simi-
lar to the SF-6D participants (Table 1).
In the SF-6D valuation, except the ‘all-worst’ state, no
other health state was valued worse than dead state. The
majority of participants (n = 681, 67%) considered the
‘all-worst’ state worse than dead. The mean valuation
score given to the ‘all-worst’ state was 12.8 (SD = 14.0)
among the participants who considered the ‘all-worst’
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valued with mean valuation score of 11.2 (SD = 12.5)
among the participants who considered the ‘all-worst’
state worse than dead. The mean valuation scores for se-
lected SF-6D health states are shown in Figure 1. For the
participants who considered the ‘all-worst’ state worse
than dead, there was a difference of more than 30 points
in the mean valuation score between the ‘all-worst’ state
(‘645655’) and its adjacent health states that are only one
level different in one dimension (‘545655’ and ‘645555’).
For the participants who considered the ‘all-worst’ state
better than dead the corresponding difference ranged
from 9 to 17 points.
Similar to the SF-6D results, only the ‘all-worst’ state
was valued worse than dead, and the majority of partici-
pants (n = 753, 74%) considered the ‘all-worst’ state worse
than dead in the EQ-5D-3L valuation. The mean valuation
score of the ‘all-worst’ state was 11.4 (SD = 12.3) among
the participants who considered the ‘all-worst’ state better
than dead; and the mean valuation score of dead was 15.2
(SD = 19.7) among the participants who considered the
‘all-worst’ state worse than dead. Similar to Figures 1, 2
also shows a difference of 25 points in the mean valuation
score between the ‘all-worst’ state (‘33333’) and its adja-
cent state ‘33323’ for the participants who considered
the ‘all-worst’ worse than dead. For the participants0
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levels of SF-6D and EQ-5D-3L dimensions in the re-
spective regression models were negative and most of
them were statistically significant (Tables 2 and 3).
Discussion
We examined the valuation of the most severe state
(labeled as ‘all-worst’) of two of the most widely used
generic instruments, SF-6D and EQ-5D-3L, using the
VAS method in a general population. We examined
the valuation score in two groups of participants - who
considered the most severe state worse than dead and
who considered it better than dead. We observed a
deficit of 20–25 points in the valuation score of the
most severe state than the adjacent states that are bet-
ter by only one level in only one dimension. The re-
gression analysis showed that this deficit could not be
explained by the differences in the health state descrip-
tors. In the SF-6D valuation, the unexplained deficit
was about 27 points and 12.3 points, respectively,
among participants who considered the most severe
state worse and better than dead. This is practically signifi-
cant, as 3.3 points was considered minimally important
difference [15,16]. In the valuation of the EQ-5D-3L, the
participants who considered the most severe state worse
than dead also scored the most severe state 15.8 points
lower than expected according to its descriptor, which isbigger than the minimally important difference of 7–8
point [16,17]. The regression models were developed
based on the comparative review and user guide for EQ-
5D value sets [4]. We used raw VAS valuation score in the
analysis without any transformations or rescaling to re-
duce artifact effect on the regression coefficients [3].
We found a deficit in value in the health state labelled
as ‘all-worst’. Participants may have valued the most se-
vere state based on the ‘all-worst’ label rather than the
objective description of it [18]. That is, the valuation
might be affected by prior belief associated with a worst
health condition or an emotional response to the hearing
of ‘all-worst’. Several studies of disease-specific health
states valuation have found that an inclusion of disease
label lowered the health state values [11]. For example, a
study found that using a label ‘breast cancer’ reduced
health state values [19]. Another study found that the
use of mental health labels such as mental handicap,
schizophrenia and dementia was associated with lower
health state values [20]. The present study showed a
similar labeling effect in a generic health state and in a
community context. Thus, we suggest to avoid labeling
health states in valuation studies.
Furthermore, the difference in the degree of deficit in
the values of the most severe state between participants
who considered the state worse than dead and those
who considered it better than dead might have been
Table 2 Summary of ordinary least-square regression on
valuation score of SF-6D health states
Regressor* Coefficient 95% confidence
interval
P-value
The most severe state worse
than dead (D1)
2.0 [0.2, 3.8] 0.029
The most severe state (D2) −12.3 [−15.8, −8.8] <0.001
Interaction of D1 and D2 −14.7 [−16.6, −12.9] <0.001
At least one severe level (N3) −2.3 [−4.3, −0.4] 0.018
Physical functioning level 2 −7.5 [−16.6, −12.9] <0.001
Physical functioning level 3 −7.9 [−9.7, −6.0] <0.001
Physical functioning level 4 −13.8 [−15.8, −11.7] <0.001
Physical functioning level 5 −13.9 [−15.9, −11.9] <0.001
Physical functioning level 6 −22.1 [−24.4, −19.9] <0.001
Role limitations level 2 −3.7 [−5.2, −2.2] <0.001
Role limitations level 3 −3.1 [−4.6, −1.6] <0.001
Role limitations level 4 −2.7 [−4.3, −1.0] 0.002
Social functioning level 2 −3.1 [−4.6, −1.5] <0.001
Social functioning level 3 −2.1 [−3.8, −0.4] 0.015
Social functioning level 4 −2.9 [−4.8, −1.1] 0.002
Social functioning level 5 −3.2 [−5.1, −1.4] 0.001
Pain level 2 −3.9 [−5.7, −2.2] <0.001
Pain level 3 −6.3 [−8.1, −4.5] <0.001
Pain level 4 −6.8 [−8.6, −4.9] <0.001
Pain level 5 −7.5 [−9.2, −5.7] <0.001
Pain level 6 −11.1 [−13.0, −9.2] <0.001
Mental health level 2 −2.1 [−3.8, −0.4] 0.016
Mental health level 3 −2.8 [−4.7, −1.0] 0.002
Mental health level 4 −4.0 [−5.9, −2.1] <0.001
Mental health level 5 −3.0 [−4.9, −1.1] 0.002
Vitality level 2 −0.3 [−2.1, 1.6] 0.785
Vitality level 3 −5.0 [−6.9, −3.2] <0.001
Vitality level 4 −5.6 [−7.6, −3.6] <0.001
Vitality level 5 −10.6 [−12.6, −8.6] <0.001
Intercept 80.2 [77.3, 83.1] <0.001
R2 = 0.519
*Adjusted for all levels of 6 dimensions of SF-6D.
Table 3 Summary of ordinary least-square regression on
valuation score of EQ-5D-3L health states
Regressor* Coefficient 95% confidence
interval
P-value
The most severe state worse
than dead (D1)
2.2 [−0.0, 4.5] 0.054
The most severe state (D2) −2.1 [−5.4, 1.1] 0.201
Interaction of D1 and D2 −13.7 [−15.8, −11.6] <0.001
At least one severe level (N3) −14.8 [−17.4, −12.1] <0.001
Mobility level 2 −8.2 [−9.4, −6.9] <0.001
Mobility level 3 −15.0 [−17.0, −13.0] <0.001
Self-care level 2 −5.1 [−6.5, −3.7] <0.001
Self-care level 3 −13.9 [−15.7, −12.2] <0.001
Usual activities level 2 −1.6 [−3.5, 0.3] 0.102
Usual activities level 3 −4.2 [−6.3, −2.0] <0.002
Pain/discomfort level 2 −5.1 [−6.3, −3.9] <0.001
Pain/discomfort level 3 −12.4 [−13.6, −11.1] <0.001
Anxiety/depression level 2 −0.3 [−1.8, 1.2] 0.674
Anxiety/depression level 3 −6.1 [−7.9, −4.2] <0.001
Intercept 79.9 [77.5, 82.3] <0.001
R2 = 0.642
*Adjusted for all levels of 5 dimensions.
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might be reluctant to value health states at the extreme
end of the VAS scale or the portion of scale near the
end. For the participants who consider the most severe
health state worse than dead, the valuation procedure in-
volved putting the card that represented the state at the
lower end of the VAS scale (score 0). Then, the
remaining health states were valued between the two
ends of the VAS scale. Thus, the other health states near
the lower end of the VAS scale might have been valued
higher than the most severe health state as a result ofend-aversion bias. On the other hand, for the partici-
pants who considered the most severe health state better
than dead, the dead state was anchored at 0 and the
most severe health state and the other health states were
valued similarly between the two ends of the VAS scale.
Our study showed that there was larger unexplained
deficit in the valuation of the most severe state in SF-6D
than EQ-5D-3L. It was likely due to differences in their
descriptive systems. It has been shown by Brazier et al.
[22] that severe SF-6D states are less severe than the se-
vere EQ-5D-3L states. That is, the participants consider
the most severe state of EQ-5D-3L almost like the worst
state based on its descriptors and hence leave less room
for the other factors which can intensify its severity,
whereas in SF-6D there is more scope for other factors,
such as the labeling effect.
It should be noted that we valued the health states
using the VAS method and hence the study findings are
applicable to this valuation method only. Further re-
search would be needed to examine if the present find-
ings are generalizable to other valuation methods like
TTO and SG.
Conclusions
We found that the most severe state was valued signifi-
cantly lower than expected according to its descriptors.
The magnitude of the deficit depended on the valuation
instrument and whether the respondents considered the
most severe state worse or better than dead.
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